TobaccoReporter logo

Tag: Bidi

  • Clashing Protests On Both Sides of Bangladesh’s Tobacco Tax Debate

    Clashing Protests On Both Sides of Bangladesh’s Tobacco Tax Debate

    Civil society groups in Bangladesh formed a human chain and called for higher tobacco taxes and pricing reforms ahead of the 2026–27 national budget at a protest in Tangail today (May 4). Organizers, including the Development Organization of the Rural Poor (DORP), urged the government to merge lower cigarette price tiers and raise minimum prices, proposing Tk100 ($0.81) per 10-stick pack for the lowest tier and a uniform 67% supplementary duty alongside a specific tax of Tk4 ($0.03) per pack. Speakers said low and mid-priced cigarettes account for nearly 90% of sales, contributing to accessibility and rising use, particularly among youth.

    Participants also highlighted the broader public health and economic impact, noting that tobacco use prevalence in Bangladesh stands at 35.3%, and that tobacco-related costs reached more than double industry revenue, and called for stronger pricing policies and alternative employment options for bidi workers as part of broader tobacco control efforts.

    Concurrently, bidi workers called for higher wages and the removal of taxes on the sector during a May Day rally organized by the Bangladesh Bidi Sramik Federation in front of the National Press Club. Workers demanded the withdrawal of taxes on the bidi industry, the elimination of advance income tax on bidis and cigarettes, improved wages, ration support, and action against counterfeit products. Union representatives also raised concerns about industry conditions and alleged financial outflows by multinational companies, while emphasizing the need for policy changes to support workers in the bidi sector.

  • Bidi Opens Latest Appeal Against FDA

    Bidi Opens Latest Appeal Against FDA

    Yesterday (April 2), Bidi Vapor LLC urged the Eleventh Circuit to reverse a U.S. Food and Drug Administration decision denying its application to market a disposable e-cigarette, saying the agency acted unlawfully. In oral arguments in Miami, attorney Eric Gotting told an appellate panel that the FDA’s decision was “arbitrary and capricious and unlawful,” and that the agency admitted adult smokers would likely switch to Bidi’s safer product—a disposable e-cigarette prefilled with tobacco-flavored e-liquid—but still denied the application.

    In January 2024, the FDA issued a marketing denial order (MDO) for the tobacco-flavored Bidi Stick-Classic disposable vape. The decision came while the agency was continuing a court-ordered second review of marketing applications for flavored Bidi Vapor products. The FDA said Bidi’s premarket tobacco application “did not demonstrate an overall net benefit to people who use tobacco products and lacked sufficient evidence to address health risks.”

    Bidi believes the FDA violated the Administrative Procedure Act and hopes to build on its record of successfully contesting adverse FDA decisions. In August 2022, the 11th Circuit set aside the original MDOs issued for its 10 non-tobacco-flavored products. That ruling put the 10 PMTAs back into scientific review and allowed those flavors to remain available for sale pursuant to the FDA’s compliance policy for deemed tobacco products.